Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer

• Katsutoshi Ando ,

  * E-mail: kando@juntendo.ac.jp

  Affiliation Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Bunkyo-Ku, Tokyo, Japan

  ⨯
• Fumiyuki Takahashi,

  Affiliation Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Bunkyo-Ku, Tokyo, Japan

  ⨯
• Motoyasu Kato,

  Affiliation Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Bunkyo-Ku, Tokyo, Japan

  ⨯
• Norihiro Kaneko,

  Affiliation Department of Respiratory Internal Medicine, Kameda Medical Center, Kamogawa-City, Chiba, Japan

  ⨯
• Tokuhide Doi,

  Affiliation Fukuoka Clinic, Adachi-Ku, Tokyo, Japan

  ⨯
• Yuichiro Ohe,

  Affiliation Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan

  ⨯
• Fumiaki Koizumi,

  Affiliation Shien-lab, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

  ⨯
• Kazuto Nishio,

  Affiliation Department of Genome Biology, Kinki University Faculty of Medicine, Higashiosaka City, Osaka, Japan

  ⨯
• Kazuhisa Takahashi

  Affiliation Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Bunkyo-Ku, Tokyo, Japan

  ⨯